Skip to main content
. 2018 Jan 8;13:189–201. doi: 10.2147/COPD.S142530

Table 2.

Comparison of baseline CXR findings in patients with or without on-treatment pneumonia (independent blinded radiologist review)

CXR finding, n (%) Pneumonia group (n=179)
Non-pneumonia group (n=50)
P-valueb LR+c LR−d Diagnostic ORe(95% CI)
Yes No Yes No
≥1 CXR findinga 179 (100) 0 50 (100) 0
Abnormal cardio/thoracic ratio measurement 53 (30)f 126 (70)g 12 (24)f 38 (76)g 0.437 1.23 0.93 1.33 (0.65, 2.75)
Atelectasis or other evidence of volume loss 31 (17) 148 (83) 9 (18) 41 (82) 0.911 0.96 1.01 0.95 (0.42, 2.16)
Basilar lines of COPD 11 (6) 168 (94) 5 (10) 45 (90) 0.344 0.61 1.04 0.59 (0.19, 1.78)
Blurring or loss of diaphragmatic shadow 21 (12) 158 (88) 5 (10) 45 (90) 0.733 1.17 0.98 1.20 (0.43, 3.35)
Calcified pleural plaque over the diaphragm or mid-chest pleural thickeningh 5 (8) 60 (92) 0 15 (100) 0.578 2.67 0.95 2.82 (0.15, 53.76)
Elevation of hemi-diaphragm (indirect sign of volume loss [any lobe]) 22 (12) 157 (88) 1 (2) 49 (98) 0.033 6.15 0.89 6.87 (0.90, 52.26)
Evidence of hiatal herniah 2 (3) 63 (97) 2 (13) 13 (87) 0.158 0.23 1.12 0.21 (0.03, 1.60)
Focal/diffuse reticular-nodular or “ground glass” shadows 11 (6) 168 (94) 5 (10) 45 (90) 0.344 0.61 1.04 0.59 (0.19, 1.78)
Hyperinflated chest 172 (96) 7 (4) 47 (94) 3 (6) 0.458 1.02 0.65 1.57 (0.39, 6.30)
Indirect signs of upper lobe volume loss (elevation of the right hilum) 20 (11) 159 (89) 11 (22) 39 (78) 0.048 0.51 1.14 0.45 (0.20, 1.01)
Large cardiac silhouette 26 (15) 153 (85) 9 (18) 41 (82) 0.546 0.81 1.04 0.77 (0.34, 1.78)
Large/prominent pulmonary artery shadow 68 (38) 111 (62) 12 (24) 38 (76) 0.067 1.58 0.82 1.94 (0.95, 3.97)
Narrow cardiac silhouette 28 (16) 151 (84) 3 (6) 47 (94) 0.101 2.61 0.90 2.91 (0.85, 9.99)
Normal heart size in a hyperinflated chest (normal cardiac silhouette) 126 (70) 53 (30) 38 (76) 12 (24) 0.437 0.93 1.23 0.75 (0.36, 1.55)
Pleural thickening (any pleural change, apical, or basal can reflect sub pulmonic effusion or diaphragm shadow being indistinct) 71 (40) 108 (60) 20 (40) 30 (60) 0.966 0.99 1.01 0.99 (0.52, 1.87)
Pleural thickening at apices 18 (10) 161 (90) 6 (12) 44 (88) 0.692 0.84 1.02 0.82 (0.31, 2.19)
Pleural thickening at bases (including costophrenic angle blunting) 25 (14) 154 (86) 7 (14) 43 (86) 0.995 1.00 1.00 1.00 (0.40, 2.46)
Signs of bronchiectasis (not common few instances outside upper lobes) 7 (4) 172 (96) 2 (4) 48 (96) 1.000 0.98 1.00 0.98 (0.20, 4.86)
Signs of congestive heart failure in addition to large heart 6 (3) 173 (97) 1 (2) 49 (98) 1.000 1.68 0.99 1.70 (0.20, 14.45)
Thick tracheal-esophageal stripe on lateral view 7 (4) 172 (96) 0 50 (100) 0.352 4.25 0.97 4.39 (0.25, 78.22)
Vascular calcification, either coronary, carotid, or within the aortic shadow 74 (41) 105 (59) 18 (36) 32 (64) 0.496 1.15 0.92 1.25 (0.65, 2.40)

Notes: Statistically significant P-values (P≤0.05) are shown in bold. Gray shading indicates CXR findings with a diagnostic OR of >2.

a

Includes patients with at least one CXR finding, excluding the finding of hyperinflated chest.

b

Chi-square test or Fisher’s exact test (the latter test was used if any values <5).

c

LR+ defined as the ratio of the likelihood of observing the CXR finding in a patient who developed on-treatment pneumonia than in a patient who did not develop on-treatment pneumonia.

d

LR− defined as the ratio of the likelihood of not observing the CXR finding in a patient who developed on-treatment pneumonia than in a patient who did not develop on-treatment pneumonia.

e

Diagnostic OR defined as the ratio of the odds of being a true positive to the odds of being a false positive. An OR of >1 indicates an association between the CXR finding and subsequent development of pneumonia, and <1 indicates an association between the CXR finding and no subsequent development of pneumonia.

f

Actual cardio/thoracic ratio measurement ratio was abnormal (<0.5 or >0.5).

g

Actual cardio/thoracic ratio measurement was normal (0.5).

h

Data missing for 114 patients in the pneumonia group and 35 patients in the non-pneumonia group; percentages are based on patients with available data.

Abbreviations: CXR, chest X-ray; LR+, positive likelihood ratio; LR−, negative likelihood ratio; OR, odds ratio.